Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
With
Washington University School of Medicine
Vanderbilt University School of Medicine
University of Washington
Duke University
Harvard University
University of Kansas Medical Center
University of Cincinnati
Loma Linda University
The study will consist of 2 treatment arms:
Treatment arm A: Intra-operative single intravenous(iv) dose of "cephalexin" 2 g or "clindamycin" 900 mg.
Treatment arm B: Intra-operative single intravenous(iv) dose of "cephalexin" 2 g or "clindamycin" 900 mg and postoperative oral dose of "cephalexin" 250mg every 4 hours or "clindamycin" 150mg every 6 hours, for a duration of three days.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients (aged 18years and older)
You may not be if
Prior rhinoplasty
Any exogenous (non-nasal) grafts/implants
Immune deficiency (DM, meds, other)
History of radiotherapy to nose
Clareo Health | Antibiotic Prophylaxis in Rhinoplasty
